Estrogen stimulates the proliferation of human endometrial cancer cells by stabilizing nucleophosmin/B23 (NPM/B23)

Journal of Molecular Medicine

Volumn 91, Issue 2, 2013, Pages 249-259

  Chao, Angel ^a   Lin, Chiao Yun ^a   Tsai, Chia Lung ^a   Hsueh, Swei ^a   Lin, Ying Yu ^a   Lin, Cheng Tao ^a   Chou, Hung Hsueh ^a   Wang, Tzu Hao ^a,b   Lai, Chyong Huey ^a   Wang, Hsin Shih ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

ARF; ER ; Estrogen; NPM B23

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; NUCLEOPHOSMIN;

ARTICLE; CELL PROLIFERATION; ENDOMETRIUM CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; UBIQUITINATION;

CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; ENDOMETRIAL NEOPLASMS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; HUMANS; NUCLEAR PROTEINS; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 84873996475     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-012-0950-8     Document Type: Article

References (35)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74-108
2. Cancer Registry Annual Report, 2008 Taiwan. http://www.bhp.doh.gov.tw/ BHPnet/Portal/StatisticsShow.aspx?No=200911300001
3. Hacker NF, Friedlander M (2009) Uterine cancer. In: Berek JS, Hacker NF (ed) Berek and Hacker's gynecologic oncology, 5th edn. Lippincott Williams & Wilkins, Philadelphia, pp 895
4. Gross JM, Yee D (2002) How does the estrogen receptor work? Breast canc res 4:62-64
5. Lim MJ, Wang XW (2006) Nucleophosmin and human cancer. Canc Detect Prev 30:481-490
6. Okuwaki M (2008) The structure and functions of NPM1/nucleophosmin/B23, a multifunctional nucleolar acidic protein. J Biochem 143:441-448
7. Hsu CY, Yung BY (1998) Down-regulation of nucleophosmin/B23 during retinoic acid-induced differentiation of human promyelocytic leukemia HL-60 cells. Oncogene 16:915-923
8. Okuda M (2002) The role of nucleophosmin in centrosome duplication. Oncogene 21:6170-6174
9. Wu MH, Chang JH, Yung BY (2002) Resistance to UV-induced cell-killing in nucleophosmin/B23 over-expressed NIH 3T3 fibroblasts: enhancement of DNA repair and up-regulation of PCNA in association with nucleophosmin/B23 over-expression. Carcinogenesis 23:93-100
10. Li J, Zhang X, Sejas DP, Bagby GC, Pang Q (2004) Hypoxia-induced nucleophosmin protects cell death through inhibition of p53. J Biol Chem 279:41275-41279
11. Lin CY, Liang YC, Yung BY (2006) Nucleophosmin/B23 regulates transcriptional activation of E2F1 via modulating the promoter binding of NF-kappaB, E2F1 and pRB. Cell Signal 18:2041-2048
12. Shields LB, Gercel-Taylor C, Yashar CM, Wan TC, Katsanis WA, Spinnato JA, Taylor DD (1997) Induction of immune responses to ovarian tumor antigens by multiparity. J Soc Gynecol Investig 4:298-304
13. Pianta A, Puppin C, Franzoni A, Fabbro D, Di Loreto C, Bulotta S, Deganuto M, Paron I, Tell G, Puxeddu E et al (2010) Nucleophosmin is overexpressed in thyroid tumors. Biochem Biophys Res Commun 397:499-504
14. Tanaka M, Sasaki H, Kino I, Sugimura T, Terada M (1992) Genes preferentially expressed in embryo stomach are predominantly expressed in gastric cancer. Cancer Res 52:3372-3377
15. Nozawa Y, Van Belzen N, Van der Made AC, Dinjens WN, Bosman FT (1996) Expression of nucleophosmin/B23 in normal and neoplastic colorectal mucosa. J Pathol 178:48-52
16. Subong EN, Shue MJ, Epstein JI, Briggman JV, Chan PK, Partin AW (1999) Monoclonal antibody to prostate cancer nuclear matrix protein (PRO:4-216) recognizes nucleophosmin/B23. Prostate 39:298-304
17. Tsui KH, Cheng AJ, Chang PL, Pan TL, Yung BY (2004) Association of nucleophosmin/B23 mRNA expression with clinical outcome in patients with bladder carcinoma. Urology 64:839-844
18. Itahana K, Bhat KP, Jin A, Itahana Y, Hawke D, Kobayashi R, Zhang Y (2003) Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation. Mol Cell 12:1151-1164
19. Colombo E, Bonetti P, Lazzerini Denchi E, Martinelli P, Zamponi R, Marine JC, Helin K, Falini B, Pelicci PG (2005) Nucleophosmin is required for DNA integrity and p19Arf protein stability. Mol Cell Biol 25:8874-8886
20. Lin CY, Tan BC, Liu H, Shih CJ, Chien KY, Lin CL, Yung BY (2010) Dephosphorylation of nucleophosmin by PP1beta facilitates pRB binding and consequent E2F1-dependent DNA repair. Mol Biol Cell 21:4409-4417
21. Skaar TC, Prasad SC, Sharareh S, Lippman ME, Brunner N, Clarke R (1998) Two-dimensional gel electrophoresis analyses identify nucleophosmin as an estrogen regulated protein associated with acquired estrogen-independence in human breast cancer cells. J Steroid Biochem Mol Biol 67:391-402
22. Zhu Y, Singh B, Hewitt S, Liu A, Gomez B, Wang A, Clarke R (2006) Expression patterns among interferon regulatory factor-1, human X-box binding protein-1, nuclear factor kappa B, nucleophosmin, estrogen receptor-alpha and progesterone receptor proteins in breast cancer tissue microarrays. Int J Oncol 28:67-76
23. Chao A, Tsai CL, Wei PC, Hsueh S, Chao AS, Wang CJ, Tsai CN, Lee YS, Wang TH, Lai CH (2010) Decreased expression of microRNA-199b increases protein levels of SET (protein phosphatase 2A inhibitor) in human choriocarcinoma. Cancer Lett 291:99-107
24. Chao A, Lin CY, Lee YS, Tsai CL, Wei PC, Hsueh S, Wu TI, Tsai CN, Wang CJ, Chao AS et al (2012) Regulation of ovarian cancer progression by microRNA-187 through targeting disabled homolog-2. Oncogene 31:764-775
25. Wang TH, Chao A, Tsai CL, Chang CL, Chen SH, Lee YS, Chen JK, Lin YJ, Chang PY, Wang CJ et al (2010) Stress-induced phosphoprotein 1 as a secreted biomarker for human ovarian cancer promotes cancer cell proliferation. Mol Cell Proteomics 9:1873-1884
26. Nishida M (2002) The Ishikawa cells from birth to the present. Hum Cell 15:104-117
27. El-Sahwi K, Bellone S, Cocco E, Cargnelutti M, Casagrande F, Bellone M, Abu-Khalaf M, Buza N, Tavassoli FA, Hui P et al (2010) In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma. Br J Cancer 102:134-143
28. Chi XZ, Kim J, Lee YH, Lee JW, Lee KS, Wee H, Kim WJ, Park WY, Oh BC, Stein GS et al (2009) Runt-related transcription factor RUNX3 is a target of MDM2-mediated ubiquitination. Cancer Res 69:8111-8119
29. Grisendi S, Mecucci C, Falini B, Pandolfi PP (2006) Nucleophosmin and cancer. Nat Rev Cancer 6:493-505
30. Yeh CW, Huang SS, Lee RP, Yung BY (2006) Ras-dependent recruitment of c-Myc for transcriptional activation of nucleophosmin/B23 in highly malignant U1 bladder cancer cells. Mol Pharmacol 70:1443-1453
31. Tawfic S, Olson MO, Ahmed K (1995) Role of protein phosphorylation in post-translational regulation of protein B23 during programmed cell death in the prostate gland. J Biol Chem 270:21009-21015
32. Chan PK (1992) Characterization and cellular localization of nucleophosmin/B23 in HeLa cells treated with selected cytotoxic agents (studies of B23-translocation mechanism). Exp Cell Res 203:174-181
33. Enomoto T, Lindstrom MS, Jin A, Ke H, Zhang Y (2006) Essential role of the B23/NPM core domain in regulating ARF binding and B23 stability. J Biol Chem 281:18463-18472
34. Liu X, Liu Z, Jang SW, Ma Z, Shinmura K, Kang S, Dong S, Chen J, Fukasawa K, Ye K (2007) Sumoylation of nucleophosmin/B23 regulates its subcellular localization, mediating cell proliferation and survival. Proc Natl Acad Sci U S A 104:9679-9684
35. Tago K, Chiocca S, Sherr CJ (2005) Sumoylation induced by the Arf tumor suppressor: a p53-independent function. Proc Natl Acad Sci U S A 102:7689-7694